A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

CNS Malignancies · Medulloblastoma Recurrent · ATRT Recurrent · Pineoblastoma · Embryonal Neoplasm · Ependymoma Recurrent · High Grade Gliomas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Principal Investigator (Eugene Hwang, MD)
    Contact: Principal Investigator (Adriana Fonseca, MD)
    Lindsay Kilburn, MD (Sub-investigator)